The NHS-Galleri trial, the first randomized, controlled trial of the multi-cancer early detection test Galleri, found that the test from GRAIL did not meet its primary endpoint, a reduction in ...
Abstract A056: Bispecific T-cell engagers and antibody-drug conjugtes for the treatment of lymphomas
1Hays Documentation Specialists LLC, San Mateo, CA.
You do not currently have access to this content.
Mol Cancer Ther (2025) 24 (10_Supplement): A045.
Rongchang Pharmaceuticals, Ltd., Shanghai, China.
The Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a ground-breaking immunotherapeutic approach in cancer treatment and demonstrated encouraging clinical results in autoimmune disease ...
Clin Cancer Res (2024) 30 (21_Supplement): A010.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results